BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25939635)

  • 1. The interferon receptor-1 promoter polymorphisms affect the outcome of Caucasians with HBeAg-negative chronic HBV infection.
    Karamitros T; Papatheodoridis G; Dimopoulou E; Papageorgiou MV; Paraskevis D; Magiorkinis G; Sypsa V; Hatzakis A
    Liver Int; 2015 Dec; 35(12):2506-13. PubMed ID: 25939635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.
    Chan HL; Tsang SW; Liew CT; Tse CH; Wong ML; Ching JY; Leung NW; Tam JS; Sung JJ
    Am J Gastroenterol; 2002 Feb; 97(2):406-12. PubMed ID: 11866280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Karamitros T; Papatheodoridis G; Paraskevis D; Hatzakis A; Mbisa JL; Georgopoulou U; Klenerman P; Magiorkinis G
    Front Immunol; 2018; 9():777. PubMed ID: 29713327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.
    Hou J; Schilling R; Janssen HL; Hansen BE; Heijtink R; Sablon E; Williams R; Lau GK; Schalm SW; Naoumov NV
    J Med Virol; 2007 Aug; 79(8):1055-63. PubMed ID: 17596838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between single-nucleotide polymorphisms and early spontaneous hepatitis B virus e antigen seroconversion in children.
    Komatsu H; Murakami J; Inui A; Tsunoda T; Sogo T; Fujisawa T
    BMC Res Notes; 2014 Nov; 7():789. PubMed ID: 25376093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus genotypes and precore/core-promoter mutations in Tunisian patients with chronic hepatitis B virus infection.
    Ayed K; Gorgi Y; Ayed-Jendoubi S; Aouadi H; Sfar I; Najjar T; Ben Abdallah T
    J Infect; 2007 Mar; 54(3):291-7. PubMed ID: 16911832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B.
    Karataylı SC; Bozdayı M; Karataylı E; Öztürk T; Husseini AA; Albayrak R; Özkan M; Kalaylıoğlu Z; Yalçın K; Çınar K; İdilman R; Yurdaydın C
    Liver Int; 2015 Mar; 35(3):846-53. PubMed ID: 24840315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
    Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
    J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection.
    Peng XM; Huang YS; Ma HH; Gu L; Xie QF; Gao ZL
    Liver Int; 2006 Apr; 26(3):326-33. PubMed ID: 16584395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DP and γ-interferon receptor-2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection.
    Lam YF; Wong DK; Seto WK; To KK; Hung IF; Fung J; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2014 Mar; 29(3):533-9. PubMed ID: 23980639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.
    Abbas Z; Muzaffar R; Siddiqui A; Naqvi SA; Rizvi SA
    BMC Gastroenterol; 2006 Jul; 6():20. PubMed ID: 16863587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon.
    Boglione L; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A
    J Viral Hepat; 2015 Mar; 22(3):318-27. PubMed ID: 25060765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
    Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
    Liver Int; 2005 Jun; 25(3):564-70. PubMed ID: 15910494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection.
    Zhou J; Lu L; Yuen MF; Lam TW; Chung CP; Lam CL; Zhang B; Wang S; Chen Y; Wu SH; Poon VK; Ng F; Chan CC; Jiang S; Yuen KY; Zheng BJ
    J Hepatol; 2007 Feb; 46(2):198-205. PubMed ID: 17125879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
    Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.
    Chen CH; Lee CM; Lu SN; Changchien CS; Eng HL; Huang CM; Wang JH; Hung CH; Hu TH
    J Clin Microbiol; 2005 Dec; 43(12):6000-6. PubMed ID: 16333089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.